Last updated: 9 July 2020 at 4:05pm EST

Mark Throsby Net Worth




The estimated Net Worth of Mark Throsby is at least $2.32 Milione dollars as of 7 July 2020. Mark Throsby owns over 368 units of Merus N.V stock worth over $2,288,494 and over the last 5 years Mark sold MRUS stock worth over $26,945.

Mark Throsby MRUS stock SEC Form 4 insiders trading

Mark has made over 13 trades of the Merus N.V stock since 2020, according to the Form 4 filled with the SEC. Most recently Mark sold 368 units of MRUS stock worth $5,689 on 7 July 2020.

The largest trade Mark's ever made was exercising 87,621 units of Merus N.V stock on 24 February 2020 worth over $4,405,584. On average, Mark trades about 6,744 units every 13 days since 2020. As of 7 July 2020 Mark still owns at least 45,515 units of Merus N.V stock.

You can see the complete history of Mark Throsby stock trades at the bottom of the page.



What's Mark Throsby's mailing address?

Mark's mailing address filed with the SEC is C/O MERUS N.V., YALELAAN 62, UTRECHT, P7, 3584 CM.

Insiders trading at Merus N.V

Over the last 5 years, insiders at Merus N.V have traded over $76,701,272 worth of Merus N.V stock and bought 4,110,523 units worth $71,063,751 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog... e Corp Incyte. On average, Merus N.V executives and independent directors trade stock every 18 days with the average trade being worth of $4,323,728. The most recent stock trade was executed by Harry Shuman on 20 August 2024, trading 5,000 units of MRUS stock currently worth $251,400.



What does Merus N.V do?

merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. our most advanced development programs use the biclonics® format. biclonics® are capable of simultaneously attacking tumors in multiple ways. for example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.



What does Merus N.V's logo look like?

Merus N.V logo

Complete history of Mark Throsby stock trades at Merus N.V

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
7 Jul 2020 Mark Throsby
EVP e Chief Scientific Officer
Vendita 368 $15.46 $5,689
7 Jul 2020
45,515
1 Jul 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 708 $16.00 $11,328
1 Jul 2020
45,883
2 Jun 2020 Mark Throsby
EVP e Chief Scientific Officer
Vendita 368 $14.19 $5,222
2 Jun 2020
45,175
1 Jun 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 708 $13.65 $9,664
1 Jun 2020
45,543
6 May 2020 Mark Throsby
EVP e Chief Scientific Officer
Vendita 368 $14.54 $5,351
6 May 2020
44,835
1 May 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 708 $13.86 $9,813
1 May 2020
45,203
2 Apr 2020 Mark Throsby
EVP e Chief Scientific Officer
Vendita 368 $10.93 $4,022
2 Apr 2020
44,495
1 Apr 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 708 $11.60 $8,213
1 Apr 2020
44,863
4 Mar 2020 Mark Throsby
EVP e Chief Scientific Officer
Vendita 368 $18.10 $6,661
4 Mar 2020
44,155
2 Mar 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 708 $17.58 $12,447
2 Mar 2020
44,523
24 Feb 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 87,621 $17.35 $1,520,224
24 Feb 2020
100,903
3 Feb 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 708 $16.92 $11,979
3 Feb 2020
13,282
2 Jan 2020 Mark Throsby
EVP e Chief Scientific Officer
Opzione 708 $13.48 $9,544
2 Jan 2020
12,574


Merus N.V executives and stock owners

Merus N.V executives and other stock owners filed with the SEC include: